01 / Contract Profile
HHSN272201700078C Federal Contract Award
Agency code 7529
NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
HHSN272201700078C contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2017 | $8.64M | 1 | — |
| FY 2018 | $8.85M | 4 | +2.3% |
| FY 2019 | $9.02M | 3 | +1.9% |
| FY 2020 | $82.24M | 6 | +812.0% |
| FY 2021 | $385.49M | 7 | +368.7% |
| FY 2022 | -$140.63M | 6 | −136.5% |
| FY 2023 | $9.68M | 2 | +106.9% |
| FY 2024 | -$23.62M | 2 | −344.0% |
| FY 2025 | -$9.84M | 1 | +58.3% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH NIAID |
05 / Contractor
Who holds this federal contract?
UEI ZANENSW6C665 · CAGE 3FAW2
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $329.84M | 32 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN81 | R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) | $329.84M | 32 | 100.0% |
08 / Place of Performance
Where is the work recorded?
ZIP 284013331
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Sep 8, 2025 | P00031 | -$9.84M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Aug 29, 2024 | P00030 | -$23.60M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Jul 8, 2024 | P00029 | -$26.0K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Jul 25, 2023 | P00028 | $9.74M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Jan 24, 2023 | P00027 | -$60.4K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Dec 20, 2022 | P00026 | -$150.76M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Aug 9, 2022 | P00025 | $9.48M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Jun 15, 2022 | P00024 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Apr 21, 2022 | P00023 | $653.1K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Feb 28, 2022 | P00022 | $3.51M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Feb 24, 2022 | P00021 | -$3.51M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Oct 13, 2021 | P00020 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Sep 24, 2021 | P00019 | -$269.9K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Aug 11, 2021 | P00018 | $291.51M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
| Jul 15, 2021 | P00017 | -$36.19M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541712 | AN81 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.